the first and only FDA approved treatment for Demodex blepharitis (DB). Demodex blepharitis occurs when Demodex mites – the most common ectoparasites found on humans – overpopulate on the eyelids.
As the first treatment cleared by the FDA for Demodex blepharitis, an eye disease estimated to affect 25 million people in the U.S. alone, Tarsus Pharmaceuticals’ Xdemvy is pitting its might ...
Dr. Yeu serves as a partner and practicing ophthalmologist at Virginia Eye Consultants, where she will continue her clinical practice. Dr. Yeu has authored hundreds of publications and is a renowned ...
Harbor Capital Advisors Inc. raised its holdings in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 57.5% in the third quarter, according to the company in its most recent filing ...